Product Description:
InVivoMAb Anti-Influenza B virus NA/Neuraminidase Broad-Neutralizing Antibody (DA03E17) is a highly effective and specific antibody designed to target and neutralize the Neuraminidase (NA) protein of the Influenza B virus. This powerful antibody is a valuable tool for researchers and scientists studying the mechanisms and treatment of Influenza B virus infections.
Biological Function:
The Neuraminidase protein is a key component of the Influenza B virus, responsible for the release of newly formed virus particles from infected cells. By targeting and binding to the NA protein, InVivoMAb Anti-Influenza B virus NA/Neuraminidase Broad-Neutralizing Antibody (DA03E17) effectively blocks this crucial step in the virus replication cycle, preventing further infection and spread.
Main Applications:
This antibody is ideal for use in a wide range of applications, including in vitro and in vivo studies of the Influenza B virus. It can be used in various assays and techniques such as Western blotting, immunoprecipitation, and immunofluorescence, to name a few. Its high specificity and potency make it a valuable tool for understanding the role of NA in Influenza B virus infections.
Experimental Use Cases:
InVivoMAb Anti-Influenza B virus NA/Neuraminidase Broad-Neutralizing Antibody (DA03E17) has been successfully used in various experimental studies. In one study, it was used to block the release of Influenza B virus particles from infected cells, leading to a significant decrease in viral replication. In another study, it was used to inhibit the spread of the virus from cell to cell, highlighting its potential as a therapeutic agent.
With its ability to specifically target and neutralize the NA protein of the Influenza B virus, InVivoMAb Anti-Influenza B virus NA/Neuraminidase Broad-Neutralizing Antibody (DA03E17) is a valuable asset for any researcher or scientist studying this infectious disease. Its high potency, specificity, and versatility make it an essential tool in the fight against Influenza B virus infections.
Keywords: InVivoMAb, Anti-Influenza B virus, NA, Neuraminidase, Broad-Neutralizing Antibody, DA03E17, virus replication, Western blotting, immunoprecipitation, immunofluorescence, therapeutic agent, infectious disease.
There are no reviews yet.